Table 2

Mutations identified in patients with BMF

Gene affectedMutationInitial diagnosisFrequency of mutation/total patients screened
TERC C35T MDS 1/200 
TERC T100A DC 1/200 
TERC 3′ del 74 bp DC 1/200 
TERC 5′ del 316 bp DC 1/200 
TERT P704S AA, DC 2/199 
TERT Y846C AA 1/199 
TERT H876Q AA 1/199 
TERT A716V AA 1/199 
TERT C1015R AA 1/199 
DKC1 Q31E DC 1/19* 
DKC1 T66A DC/HH 1/19* 
DKC1 S304N DC/HH 1/19* 
DKC1 L317V DC 1/19* 
DKC1 A353V DC, DC 2/19* 
DKC1 A386T DC 1/19* 
Gene affectedMutationInitial diagnosisFrequency of mutation/total patients screened
TERC C35T MDS 1/200 
TERC T100A DC 1/200 
TERC 3′ del 74 bp DC 1/200 
TERC 5′ del 316 bp DC 1/200 
TERT P704S AA, DC 2/199 
TERT Y846C AA 1/199 
TERT H876Q AA 1/199 
TERT A716V AA 1/199 
TERT C1015R AA 1/199 
DKC1 Q31E DC 1/19* 
DKC1 T66A DC/HH 1/19* 
DKC1 S304N DC/HH 1/19* 
DKC1 L317V DC 1/19* 
DKC1 A353V DC, DC 2/19* 
DKC1 A386T DC 1/19* 

MDS indicates myelodysplastic syndrome; DC, dyskeratosis congenita; AA, aplastic anemia; and HH, Hoyeraal Hreidarson.

*

DKC1 gene was only analyzed in male patents with clinical signs of HH, DC, or telomere lengths less than the 1st percentile.

Close Modal

or Create an Account

Close Modal
Close Modal